ERK inhibition effectively overcomes acquired resistance of epidermal growth factor receptor‐mutant non–small cell lung cancer cells to osimertinib
Findings from this study emphasize the importance of targeting MEK/ERK signaling in maintaining the long‐term benefit of osimertinib through overcoming acquired resistance to osimertinib, warranting ...
10 Dec 2019 ... https://doi.org/10.1002/cncr.32655. Citations: 1 ... Read the full text. About ... Share on. Email; Facebook; Twitter; Linked In; Reddit; Wechat ...